Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 3
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
PD-L1 expression
ovarian cancer · Immune Checkpoint Inhibitor
PD-L1 expression is flagged as cdx established context because public trials show inclusion required evidence in 6 contexts. FDA CDx context exists. Threshold text varies across public records.
Threshold snippets
Fragmentation view
Threshold count: 3
Common snippets: PD-L1 CPS ≥1 | PD-L1 CPS ≥10 | MSI-H
Threshold label: Fragmented
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT02873962 | https://clinicaltrials.gov/study/NCT02674061 | https://clinicaltrials.gov/study/NCT03410784 | https://clinicaltrials.gov/study/NCT03012620 | https://clinicaltrials.gov/study/NCT04387227 | https://clinicaltrials.gov/study/NCT05737199